OCA

Octagon Capital Advisors Portfolio holdings

AUM $799M
1-Year Est. Return 480.2%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+480.2%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$799M
AUM Growth
+$158M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
34
New
Increased
Reduced
Closed

Top Buys

1
+$18.4M
2
+$17.8M
3
+$17.7M
4
LXEO icon
Lexeo Therapeutics
LXEO
+$15.7M
5
BIOA
BioAge Labs
BIOA
+$14.2M

Top Sells

1
+$62.1M
2
+$29M
3
+$20.4M
4
COGT icon
Cogent Biosciences
COGT
+$14.7M
5
NUVB icon
Nuvation Bio
NUVB
+$9.74M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEPG icon
26
PepGen
PEPG
$428M
$4.56M 0.57%
700,000
APLS icon
27
Apellis Pharmaceuticals
APLS
$2.68B
– –
-903,500
CGON icon
28
CG Oncology
CGON
$4.86B
– –
0
GPCR icon
29
Structure Therapeutics
GPCR
$4.45B
– –
-115,000
MRUS
30
DELISTED
Merus
MRUS
– –
-308,000
NGNE icon
31
Neurogene
NGNE
$364M
– –
-252,000
NUVB icon
32
Nuvation Bio
NUVB
$2.03B
– –
-2,633,334
NUVB.WS
33
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
– –
-104,112
MAZE
34
Maze Therapeutics
MAZE
$2.19B
– –
-177,667
1
2